4-butyrolactone has been researched along with Kidney Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kivett, L; Taintor, J; Wright, J | 1 |
| Antoine, MH; Bunel, V; Duez, P; Nortier, J; Stévigny, C | 1 |
2 other study(ies) available for 4-butyrolactone and Kidney Diseases
| Article | Year |
|---|---|
Evaluation of the safety of a combination of oral administration of phenylbutazone and firocoxib in horses.
Topics: 4-Butyrolactone; Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Proteins; Creatinine; Drug Therapy, Combination; Horse Diseases; Horses; Kidney Diseases; Phenylbutazone; Prostaglandin-Endoperoxide Synthases; Sulfones | 2014 |
Nephroprotective effects of ferulic acid, Z-ligustilide and E-ligustilide isolated from Angelica sinensis against cisplatin toxicity in vitro.
Topics: 4-Butyrolactone; Acute Kidney Injury; Angelica sinensis; Antineoplastic Agents; Cell Line; Cisplatin; Collagen; Coumaric Acids; Humans; In Vitro Techniques; Kidney Diseases; Plant Extracts; Protective Agents; Reactive Oxygen Species; Wound Healing | 2015 |